Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Pneumonia | Case report

Progressive plasterer’s pneumoconiosis complicated by fibrotic interstitial pneumonia: a case report

Authors: Fumio Kurosaki, Tamiko Takemura, Masashi Bando, Tomonori Kuroki, Toshio Numao, Hiroshi Moriyama, Koichi Hagiwara

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

Although the prevalence of pneumoconiosis has been decreasing due to improvements in working conditions and regular health examinations, occupational hygiene measures are still being established. Plasterers encounter a number of hazardous materials that may be inhaled in the absence of sufficient protection.

Case presentation

A 64-year-old man who plastered without any dust protection for more than 40 years was referred to our hospital with suspected interstitial pneumonia. Mixed dust pneumoconiosis and an unusual interstitial pneumonia (UIP) pattern with fibroblastic foci were diagnosed by video-assisted thoracoscopic surgery, and an elemental analysis detected elements included in plaster work materials. Despite the cessation of plaster work and administration of nintedanib, the patient developed advanced respiratory failure.

Conclusion

Plasterers are at an increased risk of pneumoconiosis and may have a poor prognosis when complicated by the UIP pattern. Thorough dust protection and careful monitoring are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Takemura Y, Kishimoto T, Takigawa T, Kojima S, Wang BL, Sakano N, et al. Effects of mask fitness and worker education on the prevention of occupational dust exposure. Acta Med Okayama. 2008;62:75–82.PubMed Takemura Y, Kishimoto T, Takigawa T, Kojima S, Wang BL, Sakano N, et al. Effects of mask fitness and worker education on the prevention of occupational dust exposure. Acta Med Okayama. 2008;62:75–82.PubMed
2.
go back to reference Kishimoto T, Morinaga K, Kira S. The prevalence of pleural plaques and/or pulmonary changes among construction workers in Okayama, Japan. Am J Ind Med. 2000;37:291–5.CrossRef Kishimoto T, Morinaga K, Kira S. The prevalence of pleural plaques and/or pulmonary changes among construction workers in Okayama, Japan. Am J Ind Med. 2000;37:291–5.CrossRef
3.
go back to reference Stern F, Lehman E, Ruder A. Mortality among unionized construction plasterers and cement masons. Am J Ind Med. 2001;39:373–88.CrossRef Stern F, Lehman E, Ruder A. Mortality among unionized construction plasterers and cement masons. Am J Ind Med. 2001;39:373–88.CrossRef
4.
go back to reference Taskinen E, Ahlamn K, Wükeri M. A current hypothesis of the lymphatic transport of inspired dust to the parietal pleura. Chest. 1973;64:193–6.CrossRef Taskinen E, Ahlamn K, Wükeri M. A current hypothesis of the lymphatic transport of inspired dust to the parietal pleura. Chest. 1973;64:193–6.CrossRef
5.
go back to reference Egashira R, Tanaka T, Imaizumi T, Senda K, Doki Y, Kudo S, et al. Differential distribution of lymphatic clearance between upper and lower regions of the lung. Respirology. 2013;18:348–53.CrossRef Egashira R, Tanaka T, Imaizumi T, Senda K, Doki Y, Kudo S, et al. Differential distribution of lymphatic clearance between upper and lower regions of the lung. Respirology. 2013;18:348–53.CrossRef
6.
go back to reference Gulati M, Redlich CA. Asbestosis and environmental causes of usual interstitial pneumonia. Curr Opin Pulm Med. 2015;21:193–200.PubMedPubMedCentral Gulati M, Redlich CA. Asbestosis and environmental causes of usual interstitial pneumonia. Curr Opin Pulm Med. 2015;21:193–200.PubMedPubMedCentral
7.
go back to reference Arakawa H, Johkoh T, Honma K, Saito Y, Fukushima Y, Shida H, et al. Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis: its prevalence and comparison of CT findings with idiopathic pulmonary fibrosis. Chest. 2007;131:1870–6.CrossRef Arakawa H, Johkoh T, Honma K, Saito Y, Fukushima Y, Shida H, et al. Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis: its prevalence and comparison of CT findings with idiopathic pulmonary fibrosis. Chest. 2007;131:1870–6.CrossRef
8.
go back to reference Gaensler EA, Carrington CB, Coutu RE, Tomasian A, Hoffman L, Smith AA. Pathological, physiological, and radiological correlations in the pneumoconioses. Ann N Y Acad Sci. 1972;200:574–607.CrossRef Gaensler EA, Carrington CB, Coutu RE, Tomasian A, Hoffman L, Smith AA. Pathological, physiological, and radiological correlations in the pneumoconioses. Ann N Y Acad Sci. 1972;200:574–607.CrossRef
9.
go back to reference Honma K, Chiyotani K. Diffuse interstitial fibrosis in nonasbestos pneumoconiosis-a pathological study. Respiration. 1993;60:120–6.CrossRef Honma K, Chiyotani K. Diffuse interstitial fibrosis in nonasbestos pneumoconiosis-a pathological study. Respiration. 1993;60:120–6.CrossRef
10.
go back to reference Honma K, Abraham JL, Chiyotani K, De Vuyst P, Dumortier P, Gibbs AR, et al. Proposed criteria for mixed-dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol. 2004;35:1515–23.CrossRef Honma K, Abraham JL, Chiyotani K, De Vuyst P, Dumortier P, Gibbs AR, et al. Proposed criteria for mixed-dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol. 2004;35:1515–23.CrossRef
11.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.CrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.CrossRef
12.
go back to reference Hoshi S, Tamai Y, Tamura A, Ishida H, Yoshida N, Ogawa C, et al. Silico-asbestosis that responded to steroid therapy. Intern Med. 2006;45:917–21.CrossRef Hoshi S, Tamai Y, Tamura A, Ishida H, Yoshida N, Ogawa C, et al. Silico-asbestosis that responded to steroid therapy. Intern Med. 2006;45:917–21.CrossRef
13.
go back to reference Kishimoto T, Yamamoto H, Morinaga K, Yamawaki Y, Yoshimoto T, Miyashita T, et al. Clinical, pathological and mineralogical features in two autopsy cases of workers exposed to agalmatolite dust. Ind Health. 1999;37:432–9.CrossRef Kishimoto T, Yamamoto H, Morinaga K, Yamawaki Y, Yoshimoto T, Miyashita T, et al. Clinical, pathological and mineralogical features in two autopsy cases of workers exposed to agalmatolite dust. Ind Health. 1999;37:432–9.CrossRef
14.
go back to reference Tanaka J, Moriyama H, Terada M, Takada T, Suzuki E, Narita I, et al. An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease. BMJ Open. 2014;4:e004407.CrossRef Tanaka J, Moriyama H, Terada M, Takada T, Suzuki E, Narita I, et al. An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease. BMJ Open. 2014;4:e004407.CrossRef
15.
go back to reference Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, et al. Pathology of asbestosis- an update of the diagnostic criteria: report of the asbestosis committee of the college of American pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010;134:462–80.PubMed Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, et al. Pathology of asbestosis- an update of the diagnostic criteria: report of the asbestosis committee of the college of American pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010;134:462–80.PubMed
16.
go back to reference Ferreira PG, Ferreira AJ, Carvalho LM, Luís AS. Mixed pneumoconiosis due to silicates and hard metals associated with primary Sjögren's syndrome due to silica. J Bras Pneumol. 2014;40:92–5.CrossRef Ferreira PG, Ferreira AJ, Carvalho LM, Luís AS. Mixed pneumoconiosis due to silicates and hard metals associated with primary Sjögren's syndrome due to silica. J Bras Pneumol. 2014;40:92–5.CrossRef
17.
go back to reference Okabayashi K, Yamaguchi T, Amano H, Nakagawa A, Takao T, Tamaki M, et al. Pronounced progression of interstitial pneumonia in a precious metal worker. Nihon Kokyuki Gakkai Zasshi. 1999;37:549–53 [Article in Japanese].PubMed Okabayashi K, Yamaguchi T, Amano H, Nakagawa A, Takao T, Tamaki M, et al. Pronounced progression of interstitial pneumonia in a precious metal worker. Nihon Kokyuki Gakkai Zasshi. 1999;37:549–53 [Article in Japanese].PubMed
18.
go back to reference Harada T, Watanabe K, Nabeshima K, Hamasaki M, Iwasaki H. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia. Respirology. 2013;18:278–83.CrossRef Harada T, Watanabe K, Nabeshima K, Hamasaki M, Iwasaki H. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia. Respirology. 2013;18:278–83.CrossRef
19.
go back to reference Shah SH, Nagymanyoki Z, Ramaiya NH, Howard S. AIRP best cases in radiologic-pathologic correlation: coal workers’ pneumoconiosis. Radiographics. 2012;32:2047–52.CrossRef Shah SH, Nagymanyoki Z, Ramaiya NH, Howard S. AIRP best cases in radiologic-pathologic correlation: coal workers’ pneumoconiosis. Radiographics. 2012;32:2047–52.CrossRef
20.
go back to reference Khalil N, Churg A, Muller N, O'Connor R. Environmental, inhaled and ingested causes of pulmonary fibrosis. Toxicol Pathol. 2007;35:86–96.CrossRef Khalil N, Churg A, Muller N, O'Connor R. Environmental, inhaled and ingested causes of pulmonary fibrosis. Toxicol Pathol. 2007;35:86–96.CrossRef
21.
go back to reference Marchand-Adam S, El Khatib A, Guillon F, Brauner MW, Lamberto C, Lepage V, et al. Short- and long-term response to corticosteroid therapy in chronic beryllium disease. Eur Respir J. 2008;32:687–93.CrossRef Marchand-Adam S, El Khatib A, Guillon F, Brauner MW, Lamberto C, Lepage V, et al. Short- and long-term response to corticosteroid therapy in chronic beryllium disease. Eur Respir J. 2008;32:687–93.CrossRef
22.
go back to reference Zacharisen MC, Fink JN. Hypersensitivity pneumonitis and related conditions in the work environment. Immunol Allergy Clin N Am. 2011;31:769–86.CrossRef Zacharisen MC, Fink JN. Hypersensitivity pneumonitis and related conditions in the work environment. Immunol Allergy Clin N Am. 2011;31:769–86.CrossRef
Metadata
Title
Progressive plasterer’s pneumoconiosis complicated by fibrotic interstitial pneumonia: a case report
Authors
Fumio Kurosaki
Tamiko Takemura
Masashi Bando
Tomonori Kuroki
Toshio Numao
Hiroshi Moriyama
Koichi Hagiwara
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-018-0776-4

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.